UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma
NCT01884688
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Asymptomatic Multiple Myeloma
Interventions
DRUG:
ENK Cell Infusion
Sponsor
University of Arkansas
Collaborators
[object Object]